Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

How do autoimmune diseases cluster in families? A systematic review and meta-analysis.
Natalizumab and multiple sclerosis.
[Adaptative immunity and pathophysiology of multiple sclerosis.]
Immune-mediated processes in neurodegeneration: where do we stand?
Studies in Experimental Autoimmune Encephalomyelitis Do Not Support Developmental Bisphenol A Exposure as an Environmental Factor in Increasing Multiple Sclerosis Risk.
Neurogenic detrusor overactivity is associated with decreased expression and function of the large conductance voltage- and ca(2+)-activated k(+) channels.
Elevated and dysregulated bone morphogenic proteins in immune cells of patients with relapsing-remitting multiple sclerosis.
[Relationship between biochemical parameters of cerebrospinal fluid and the course of multiple sclerosis.]
Apolipoproteins are associated with new MRI lesions and deep grey matter atrophy in clinically isolated syndromes.
HIV and lower risk of multiple sclerosis: beginning to unravel a mystery using a record-linked database study.
Treatment Against Human Endogenous Retrovirus: A Possible Personalized Medicine Approach for Multiple Sclerosis.
Intracranial delivery of interleukin-17A via adeno-associated virus fails to induce physical and learning disabilities and neuroinflammation in mice but improves glucose metabolism through AKT signaling pathway.
The neuroimaging of Leigh syndrome: case series and review of the literature.
[Effects of caffeine citrate on myelin basic protein in neonatal rats with hypoxic-ischemic brain damage].
Prophylactic Effect of BIO-1211 Small-Molecule Antagonist of VLA-4 in the EAE Mouse Model of Multiple Sclerosis.
A 10-year population-based study of people with multiple sclerosis in Stockholm, Sweden: use of and satisfaction with care and the value of different factors in predicting use of care.
Control of Human PLP1 Expression Through Transcriptional Regulatory Elements and Alternatively Spliced Exons in Intron 1.
Estimating the marginal effect of socioeconomic factors on the demand of specialty drugs.
Glatiramer acetate-induced hepatitis in a patient with multiple sclerosis.
Asynchrony in Executive Networks Predicts Cognitive Slowing in Multiple Sclerosis.
Innate Immunotherapeutics announces clinical trial fully enrolled and receives strong interest from potential Pharma partners
Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis.
Regulatory dendritic cell therapy: From rodents to clinical application.
Epidemiological, humanistic, and economic burden of illness of lower limb spasticity in adults: a systematic review.
The role of KIR2DS1 in multiple sclerosis: KIR in Portuguese MS patients.

Pages